rs2229207
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001289125.3(IFNAR2):c.23T>C(p.Phe8Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0834 in 1,608,462 control chromosomes in the GnomAD database, including 6,307 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001289125.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IFNAR2 | NM_001289125.3 | c.23T>C | p.Phe8Ser | missense_variant | 2/9 | ENST00000342136.9 | |
IFNAR2-IL10RB | NM_001414505.1 | c.23T>C | p.Phe8Ser | missense_variant | 2/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IFNAR2 | ENST00000342136.9 | c.23T>C | p.Phe8Ser | missense_variant | 2/9 | 1 | NM_001289125.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0917 AC: 13949AN: 152094Hom.: 694 Cov.: 32
GnomAD3 exomes AF: 0.103 AC: 25757AN: 249278Hom.: 1509 AF XY: 0.102 AC XY: 13711AN XY: 134802
GnomAD4 exome AF: 0.0825 AC: 120178AN: 1456250Hom.: 5608 Cov.: 29 AF XY: 0.0842 AC XY: 61009AN XY: 724626
GnomAD4 genome AF: 0.0917 AC: 13963AN: 152212Hom.: 699 Cov.: 32 AF XY: 0.0971 AC XY: 7227AN XY: 74422
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Mortality risk in patients with severe coronavirus disease (COVID-19) Uncertain:1
Uncertain significance, no assertion criteria provided | research | HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas | May 06, 2022 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 29% of patients studied by a panel of primary immunodeficiencies. Number of patients: 28. Only high quality variants are reported. - |
Immunodeficiency 45 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Hepatitis B virus, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jun 13, 2006 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at